SCV-07 (SciClone Pharmaceuticals/Verta).

@article{Aspinall2006SCV07P,
  title={SCV-07 (SciClone Pharmaceuticals/Verta).},
  author={Richard J. Aspinall and Paul J. Pockros},
  journal={Current opinion in investigational drugs},
  year={2006},
  volume={7 2},
  pages={180-5}
}
SciClone Pharmaceuticals and Verta are developing SCV-07, the lead in a series of immnunostimulants from Verta, for the potential treatment of tuberculosis and hepatitis C virus infection. Phase II clinical trials of the compound are ongoing. 

From This Paper

Figures, tables, results, connections, and topics extracted from this paper.
3 Extracted Citations
0 Extracted References
Similar Papers

Citing Papers

Publications influenced by this paper.
Showing 1-3 of 3 extracted citations

Similar Papers

Loading similar papers…